Semler Scientific (Nasdaq: SMLR) is riding the Bitcoin wave! Shares surged over 2.64% to $35.37 today as the company revealed its Q2 2025 earnings, fueled by a surprising boost: unrealized gains from its Bitcoin stash. Could this crypto strategy be the key to Semler’s future growth?
Semler Scientific [Ticker: SMLR] announces Q2 2025 results, showcasing a strategic focus on Bitcoin. As of July 31, 2025, the company holds 5,021 BTC, realizing a remarkable 31.3% yeartodate yield.
Joe Burnett, MSBA (@IIICapital) August 4, 2025
From near-zero to hero, that’s the story of this quarter’s earnings. Buckle up: net income skyrocketed to $66.9 million, a jaw-dropping leap from last year’s meager $11,000. How? It’s a tale of two forces. Revenue took a nosedive, plummeting 43% to $8.2 million. Operating expenses also ballooned to $10.3 million, resulting in a $2.1 million operating loss. But here’s the plot twist: a Bitcoin bonanza! The company’s $83.8 million unrealized gain on its Bitcoin holdings sent pre-tax income soaring to a staggering $80.6 million. A digital ace in the hole transformed red ink into a golden opportunity.
Semler Scientific’s Bitcoin gamble is paying off big time. Executive Chairman Eric Semler announced a staggering $110.4 million in unrealized gains year-to-date through July, boasting a 31.3% Bitcoin yield. But they’re not just hodling; they’re diving headfirst into the crypto ecosystem. Semler solidified their commitment by welcoming Bitcoin thought leaders Natalie Brunell to the board and tapping Joe Burnett as Director of Bitcoin Strategy. This isn’t just investment; it’s a full-fledged embrace of the future of finance.
Semler aggressively expanded its Bitcoin holdings, now boasting 5,021 coins valued at $586.2 million as of July 31, 2025. This surge, fueled by strategic acquisitions, saw the company add roughly 1,829 Bitcoins between the start of Q3 and the end of July. The buying spree, totaling $195.4 million, was financed through a trifecta of sources: robust operating cash flow, savvy investment monetization, and strategic equity and debt offerings.
Semler Scientific is betting big on a two-pronged future. CEO Doug Murphy-Chutorian announced the launch of CardioVanta, a new subsidiary laser-focused on revolutionizing early detection of heart failure and cardiac arrhythmia. But that’s not all. While CardioVanta pioneers advancements in healthcare, Semler remains committed to its bold Bitcoin treasury strategy. Murphy-Chutorian envisions Semler Scientific as a “dual-engine platform for growth,” fueled by both cutting-edge medical innovation and a forward-thinking financial strategy.
Semler Scientific didn’t just launch a new subsidiary; it also unlocked a potential $500 million war chest in April through a new at-the-market (ATM) equity offering. Imagine that: the ability to issue and sell up to half a billion dollars in common stock. By July 31, the company had already tapped into this financial reservoir, raising approximately $194.3 million.
Semler Scientific just unlocked a powerful new financial tool. They’ve signed an agreement for an “at-the-market” (ATM) offering, teaming up with Barclays, Cantor Fitzgerald, Canaccord Genuity, Needham & Company, Craig-Hallum, and Lake Street Capital Markets. Think of it as a flexible financial lifeline, allowing them to strategically sell shares over time, capitalizing on market opportunities. This ATM offering provides Semler with increased financial agility and potential for growth.
Those interested can watch the full Semler Scientific Q2 2025 earnings call below for more information:
Semler Scientific (SMLR) stock is surging! What’s fueling the fire? Bitcoin gains, igniting a stellar Q2 performance. Originally reported by Oscar Zarraga Perez in Bitcoin Magazine, the ripple effect of crypto’s resurgence is now palpably boosting this intriguing player in the healthcare space.
Thanks for reading Semler Scientific Stock SMLR Rises After Bitcoin Gains Fuel Q2 Results
